메뉴 건너뛰기




Volumn 6, Issue 6, 2014, Pages 1464-1473

Monoclonal antibodies biosimilarity assessment using transient isotachophoresis capillary zone electrophoresis-tandem mass spectrometry

Author keywords

Biobetter; Biosimilar; Cetuximab; Complete sequence coverage; Glycoforms semiquantitative analysis; Glycosylations; Mass spectrometry; Monoclonal antibodies; Peptide mapping; Posttranslational modifications; Sheathless capillary electrophoresis; Transient isotachophoresis; Trastuzumab

Indexed keywords

AMINO ACID; BIOSIMILAR AGENT; CETUXIMAB; GLYCOPROTEIN; MONOCLONAL ANTIBODY; TRASTUZUMAB; POLYSACCHARIDE;

EID: 84920847485     PISSN: 19420862     EISSN: 19420870     Source Type: Journal    
DOI: 10.4161/mabs.36305     Document Type: Article
Times cited : (57)

References (47)
  • 2
    • 84872503060 scopus 로고    scopus 로고
    • Characterization of therapeutic antibodies and related products
    • PMID:23134362
    • Beck A, Wagner-Rousset E, Ayoub D, Van Dorsselaer A, Sanglier-Cianferani S. Characterization of therapeutic antibodies and related products. Anal Chem 2013; 85:715-36; PMID:23134362; http://dx.doi.org/ 10.1021/ac3032355
    • (2013) Anal Chem , vol.85 , pp. 715-736
    • Beck, A.1    Wagner-Rousset, E.2    Ayoub, D.3    Van Dorsselaer, A.4    Sanglier-Cianferani, S.5
  • 3
    • 77951586447 scopus 로고    scopus 로고
    • Strategies and challenges for the next generation of therapeutic antibodies
    • PMID:20414207
    • Beck A, Wurch T, Bailly C, Corvaia N. Strategies and challenges for the next generation of therapeutic antibodies. Nat Rev Immunol 2010; 10:345-52; PMID:20414207; http://dx.doi.org/10.1038/nri2747
    • (2010) Nat Rev Immunol , vol.10 , pp. 345-352
    • Beck, A.1    Wurch, T.2    Bailly, C.3    Corvaia, N.4
  • 4
    • 84880128705 scopus 로고    scopus 로고
    • Antibodies to watch in 2013: Mid-year update
    • PMID:23727858
    • Reichert JM. Antibodies to watch in 2013: Mid-year update. mAbs 2013; 5:513-7; PMID:23727858; http://dx.doi.org/10.4161/mabs.24990
    • (2013) MAbs , vol.5 , pp. 513-517
    • Reichert, J.M.1
  • 5
    • 84931269017 scopus 로고    scopus 로고
    • Therapeutic human monoclonal antibodies in inflammatory diseases
    • PMID:24037835
    • Kotsovilis S, Andreakos E. Therapeutic human monoclonal antibodies in inflammatory diseases. Methods Mol Biol 2014; 1060:37-59; PMID:24037835; http:// dx.doi.org/10.1007/978-1-62703-586-6-3
    • (2014) Methods Mol Biol , vol.1060 , pp. 37-59
    • Kotsovilis, S.1    Andreakos, E.2
  • 6
    • 0037350545 scopus 로고    scopus 로고
    • Immunotherapy: Past, present and future
    • PMID:12612576
    • Waldmann TA. Immunotherapy: past, present and future. Nat Med 2003; 9:269-77; PMID:12612576; http://dx.doi.org/10.1038/nm0303-269
    • (2003) Nat Med , vol.9 , pp. 269-277
    • Waldmann, T.A.1
  • 8
    • 84883880492 scopus 로고    scopus 로고
    • Approval of the first biosimilar antibodies in Europe: A major landmark for the biopharmaceutical industry
    • PMID: 23924791
    • Beck A, Reichert JM. Approval of the first biosimilar antibodies in Europe: A major landmark for the biopharmaceutical industry. mAbs 2013; 5:621-3; PMID: 23924791; http://dx.doi.org/10.4161/mabs.25864
    • (2013) MAbs , vol.5 , pp. 621-623
    • Beck, A.1    Reichert, J.M.2
  • 10
    • 84896536985 scopus 로고    scopus 로고
    • Middle-down analysis of monoclonal antibodies with electron transfer dissociation orbitrap fourier transform mass spectrometry
    • PMID:24588056
    • Fornelli L, Ayoub D, Aizikov K, Beck A, Tsybin YO. Middle-down analysis of monoclonal antibodies with electron transfer dissociation orbitrap fourier transform mass spectrometry. Anal Chem 2014; 86:3005-12; PMID:24588056; http://dx.doi.org/10.1021/ ac4036857
    • (2014) Anal Chem , vol.86 , pp. 3005-3012
    • Fornelli, L.1    Ayoub, D.2    Aizikov, K.3    Beck, A.4    Tsybin, Y.O.5
  • 12
    • 84861842454 scopus 로고    scopus 로고
    • Biosimilar, biobetter, and next generation antibody characterization by mass spectrometry
    • PMID:22510259
    • Beck A, Sanglier-Cianférani S, Van Dorsselaer A. Biosimilar, biobetter, and next generation antibody characterization by mass spectrometry. Anal Chem 2012; 84:4637-46; PMID:22510259; http://dx.doi.org/ 10.1021/ac3002885
    • (2012) Anal Chem , vol.84 , pp. 4637-4646
    • Beck, A.1    Sanglier-Cianférani, S.2    Van Dorsselaer, A.3
  • 13
    • 84869809294 scopus 로고    scopus 로고
    • Characterization of antibody variants during process development: The tale of incomplete processing of N-terminal secretion peptide
    • PMID:22932441
    • Ambrogelly A, Liu Y-H, Li H, Mengisen S, Yao B, Xu W, Cannon-Carlson S. Characterization of antibody variants during process development: the tale of incomplete processing of N-terminal secretion peptide. mAbs 2012; 4:701-9; PMID:22932441; http://dx.doi.org/ 10.4161/mabs.21614
    • (2012) MAbs , vol.4 , pp. 701-709
    • Ambrogelly, A.1    Liu, Y.-H.2    Li, H.3    Mengisen, S.4    Yao, B.5    Xu, W.6    Cannon-Carlson, S.7
  • 15
    • 70349762761 scopus 로고    scopus 로고
    • Electrospray ionization quadrupole ion-mobility time-of-flight mass spectrometry as a tool to distinguish the lot-to-lot heterogeneity in N-glycosylation profile of the therapeutic monoclonal antibody trastuzumab
    • PMID:19744865
    • Damen CN, Chen W, Chakraborty A, Oosterhout M, Mazzeo J, Gebler J, Schellens JM, Rosing H, Beijnen J. Electrospray ionization quadrupole ion-mobility time-of-flight mass spectrometry as a tool to distinguish the lot-to-lot heterogeneity in N-glycosylation profile of the therapeutic monoclonal antibody trastuzumab. J Am Soc Mass Spectrom 2009; 20:2021-33; PMID:19744865; http://dx.doi.org/10.1016/j.jasms. 2009.07.017
    • (2009) J Am Soc Mass Spectrom , vol.20 , pp. 2021-2033
    • Damen, C.N.1    Chen, W.2    Chakraborty, A.3    Oosterhout, M.4    Mazzeo, J.5    Gebler, J.6    Schellens, J.M.7    Rosing, H.8    Beijnen, J.9
  • 16
    • 80054969608 scopus 로고    scopus 로고
    • Use of CE-SDS gel for characterization of monoclonal antibody hinge region clipping due to copper and high pH stress
    • PMID:22145164
    • Rustandi RR, Wang Y. Use of CE-SDS gel for characterization of monoclonal antibody hinge region clipping due to copper and high pH stress. Electrophoresis 2011; 32:3078-84; PMID:22145164; http://dx.doi. org/10.1002/elps.201100186
    • (2011) Electrophoresis , vol.32 , pp. 3078-3084
    • Rustandi, R.R.1    Wang, Y.2
  • 17
    • 84862530792 scopus 로고    scopus 로고
    • Charge heterogeneity of monoclonal antibodies by multiplexed imaged capillary isoelectric focusing immunoassay with chemiluminescence detection
    • PMID:22663182
    • Michels DA, Tu AW, McElroy W, Voehringer D, Salas-Solano O. Charge heterogeneity of monoclonal antibodies by multiplexed imaged capillary isoelectric focusing immunoassay with chemiluminescence detection. Anal Chem 2012; 84:5380-6; PMID:22663182; http://dx.doi.org/10.1021/ac3008847
    • (2012) Anal Chem , vol.84 , pp. 5380-5386
    • Michels, D.A.1    Tu, A.W.2    McElroy, W.3    Voehringer, D.4    Salas-Solano, O.5
  • 18
    • 84889818943 scopus 로고    scopus 로고
    • Analytical characterization of a monoclonal antibody therapeutic reveals a three-light chain species that is efficiently removed using hydrophobic interaction chromatography
    • PMID:23995619
    • Wollacott RB, Casaz PL, Morin TJ, Zhu HL, Anderson RS, Babcock GJ, Que J, Thomas WD, Ozturk SS. Analytical characterization of a monoclonal antibody therapeutic reveals a three-light chain species that is efficiently removed using hydrophobic interaction chromatography. Mabs 2013; 5:925-35; PMID:23995619; http://dx.doi.org/10.4161/mabs.26192
    • (2013) Mabs , vol.5 , pp. 925-935
    • Wollacott, R.B.1    Casaz, P.L.2    Morin, T.J.3    Zhu, H.L.4    Anderson, R.S.5    Babcock, G.J.6    Que, J.7    Thomas, W.D.8    Ozturk, S.S.9
  • 19
    • 44949213072 scopus 로고    scopus 로고
    • Towards absolute quantification of therapeutic monoclonal antibody in serum by LC-MSMS using isotope-labeled antibody standard and protein cleavage isotope dilution mass spectrometry
    • PMID: 18465883
    • Heudi O, Barteau S, Zimmer D, Schmidt J, Bill K, Lehmann N, Bauer C, Kretz O. Towards absolute quantification of therapeutic monoclonal antibody in serum by LC-MSMS using isotope-labeled antibody standard and protein cleavage isotope dilution mass spectrometry. Anal Chem 2008; 80:4200-7; PMID: 18465883; http://dx.doi.org/10.1021/ac800205s
    • (2008) Anal Chem , vol.80 , pp. 4200-4207
    • Heudi, O.1    Barteau, S.2    Zimmer, D.3    Schmidt, J.4    Bill, K.5    Lehmann, N.6    Bauer, C.7    Kretz, O.8
  • 22
    • 84908606572 scopus 로고    scopus 로고
    • Theory and practice of size exclusion chromatography for the analysis of protein aggregates
    • PMID:24816223
    • Fekete S, Beck A, Veuthey J-L, Guillarme D. Theory and practice of size exclusion chromatography for the analysis of protein aggregates. J Pharm Biomed Anal 2014; 101:161-173; PMID:24816223; http://dx.doi. org/10.1016/j.jpba.2014.04.011
    • (2014) J Pharm Biomed Anal , vol.101 , pp. 161-173
    • Fekete, S.1    Beck, A.2    Veuthey, J.-L.3    Guillarme, D.4
  • 23
    • 84875490083 scopus 로고    scopus 로고
    • Rapid and multi-level characterization of trastuzumab using sheathless capillary electrophoresis-tandem mass spectrometry
    • PMID:23563524
    • Gahoual R, Burr A, Busnel J-M, Kuhn L, Hammann P, Beck A, François Y-N, Leize-Wagner E. Rapid and multi-level characterization of trastuzumab using sheathless capillary electrophoresis-tandem mass spectrometry. mAbs 2013; 5:479-90; PMID:23563524; http://dx.doi.org/10.4161/mabs.23995
    • (2013) MAbs , vol.5 , pp. 479-490
    • Gahoual, R.1    Burr, A.2    Busnel, J.-M.3    Kuhn, L.4    Hammann, P.5    Beck, A.6    François, Y.-N.7    Leize-Wagner, E.8
  • 24
    • 34250185717 scopus 로고    scopus 로고
    • Simplifying CE-MS operation. 2. Interfacing low-flow separation techniques to mass spectrometry using a porous tip
    • PMID:17447730
    • Moini M. Simplifying CE-MS Operation. 2. Interfacing Low-Flow Separation Techniques to Mass Spectrometry Using a Porous Tip. Anal Chem 2007; 79:4241-6; PMID:17447730; http://dx.doi.org/ 10.1021/ac0704560
    • (2007) Anal Chem , vol.79 , pp. 4241-4246
    • Moini, M.1
  • 25
    • 78149357330 scopus 로고    scopus 로고
    • Performance of a sheathless porous tip sprayer for capillary electrophoresis-electrospray ionization-mass spectrometry of intact proteins
    • PMID:20970804
    • Haselberg R, Ratnayake CK, de Jong GJ, Somsen GW. Performance of a sheathless porous tip sprayer for capillary electrophoresis-electrospray ionization-mass spectrometry of intact proteins. J Chromatogr A 2010; 1217:7605-11; PMID:20970804; http://dx.doi.org/ 10.1016/j.chroma.2010.10.006
    • (2010) J Chromatogr A , vol.1217 , pp. 7605-7611
    • Haselberg, R.1    Ratnayake, C.K.2    De Jong, G.J.3    Somsen, G.W.4
  • 26
    • 78449269358 scopus 로고    scopus 로고
    • High capacity capillary electrophoresis-electrospray ionization mass spectrometry: Coupling a porous sheathless interface with tran-sient-isotachophoresis
    • PMID:21028888
    • Busnel J-M, Schoenmaker B, Ramautar R, Carrasco-Pancorbo A, Ratnayake C, Feitelson JS, Chapman JD, Deelder AM, Mayboroda OA. High capacity capillary electrophoresis-electrospray ionization mass spectrometry: coupling a porous sheathless interface with tran-sient-isotachophoresis. Anal Chem 2010; 82:9476-83; PMID:21028888; http://dx.doi.org/10.1021/ ac102159d
    • (2010) Anal Chem , vol.82 , pp. 9476-9483
    • Busnel, J.-M.1    Schoenmaker, B.2    Ramautar, R.3    Carrasco-Pancorbo, A.4    Ratnayake, C.5    Feitelson, J.S.6    Chapman, J.D.7    Deelder, A.M.8    Mayboroda, O.A.9
  • 27
    • 84884400938 scopus 로고    scopus 로고
    • Comparing and combining capillary electrophoresis electrospray ionization mass spectrometry and nano-liquid chromatography electrospray ionization mass spectrometry for the characterization of posttranslationally modified histones
    • PMID:23720761
    • Sarg B, Faserl K, Kremser L, Halfinger B, Sebastiano R, Lindner HH. Comparing and combining capillary electrophoresis electrospray ionization mass spectrometry and nano-liquid chromatography electrospray ionization mass spectrometry for the characterization of posttranslationally modified histones. Mol Cell Proteomics 2013; 12:2640-56; PMID:23720761; http://dx.doi. org/10.1074/mcp.M112.024109
    • (2013) Mol Cell Proteomics , vol.12 , pp. 2640-2656
    • Sarg, B.1    Faserl, K.2    Kremser, L.3    Halfinger, B.4    Sebastiano, R.5    Lindner, H.H.6
  • 28
    • 84855955383 scopus 로고    scopus 로고
    • Enhancing the coverage of the urinary metabolome by sheathless capillary electrophoresis-mass spectrometry
    • PMID:22148170
    • Ramautar R, Busnel JM, Deelder AM, Mayboroda OA. Enhancing the coverage of the urinary metabolome by sheathless capillary electrophoresis-mass spectrometry. Anal Chem 2012; 84:885-92; PMID:22148170; http://dx.doi.org/10.1021/ac202407v
    • (2012) Anal Chem , vol.84 , pp. 885-892
    • Ramautar, R.1    Busnel, J.M.2    Deelder, A.M.3    Mayboroda, O.A.4
  • 29
    • 84858959679 scopus 로고    scopus 로고
    • Evaluation of a sheathless nanospray interface based on a porous tip sprayer for CE-ESI-MS coupling
    • PMID:22451047
    • Bonvin G, Veuthey JL, Rudaz S, Schappler J. Evaluation of a sheathless nanospray interface based on a porous tip sprayer for CE-ESI-MS coupling. Electrophoresis 2012; 33:552-62; PMID:22451047; http:// dx.doi.org/10.1002/elps.201100461
    • (2012) Electrophoresis , vol.33 , pp. 552-562
    • Bonvin, G.1    Veuthey, J.L.2    Rudaz, S.3    Schappler, J.4
  • 30
    • 84894903134 scopus 로고    scopus 로고
    • Novel sheathless CE-MS interface as an original and powerful infusion platform for nanoESI study: From intact proteins to high molecular mass noncovalent complexes
    • PMID:23881366
    • Gahoual R, Busnel J-M, Wolff P, Fraņcois Y, Leize-Wagner E. Novel sheathless CE-MS interface as an original and powerful infusion platform for nanoESI study: from intact proteins to high molecular mass noncovalent complexes. Anal Bioanal Chem 2014; 406:1029-38; PMID:23881366; http://dx.doi.org/ 10.1007/s00216-013-7226-1
    • (2014) Anal Bioanal Chem , vol.406 , pp. 1029-1038
    • Gahoual, R.1    Busnel, J.-M.2    Wolff, P.3    Fraņcois, Y.4    Leize-Wagner, E.5
  • 31
    • 0033821046 scopus 로고    scopus 로고
    • Transient isotachophoresis for sensitivity enhancement in capillary electrophoresismass spectrometry for peptide analysis
    • PMID:11001295
    • Larsson M, Lutz ESM. Transient isotachophoresis for sensitivity enhancement in capillary electrophoresismass spectrometry for peptide analysis. Electrophoresis 2000; 21:2859-65; PMID:11001295; http://dx.doi. org/10.1002/1522-2683(20000801)21:14%3c2859:: AID-ELPS2859%3e3.0.CO;2-F
    • (2000) Electrophoresis , vol.21 , pp. 2859-2865
    • Larsson, M.1    Lutz, E.S.M.2
  • 32
    • 17444403242 scopus 로고    scopus 로고
    • Structural basis for inhibition of the epidermal growth factor receptor by cetuximab
    • PMID:15837620
    • Li S, Schmitz KR, Jeffrey PD, Wiltzius JJW, Kussie P, Ferguson KM. Structural basis for inhibition of the epidermal growth factor receptor by cetuximab. Cancer Cell 2005; 7:301-11; PMID:15837620; http://dx.doi. org/10.1016/j.ccr.2005.03.003
    • (2005) Cancer Cell , vol.7 , pp. 301-311
    • Li, S.1    Schmitz, K.R.2    Jeffrey, P.D.3    Wiltzius, J.J.W.4    Kussie, P.5    Ferguson, K.M.6
  • 33
    • 84877913457 scopus 로고    scopus 로고
    • Gastric cancer and trastuzumab: First biologic therapy in gastric cancer
    • PMID:23450234
    • Gunturu KSW, Woo Y, Beaubier N, Remotti HE, Saif WM. Gastric cancer and trastuzumab: first biologic therapy in gastric cancer. Ther Adv Med Oncol 2013; 5:143-51; PMID:23450234; http://dx.doi.org/ 10.1177/1758834012469429
    • (2013) Ther Adv Med Oncol , vol.5 , pp. 143-151
    • Gunturu, K.S.W.1    Woo, Y.2    Beaubier, N.3    Remotti, H.E.4    Saif, W.M.5
  • 34
    • 41149093491 scopus 로고    scopus 로고
    • Immunopurification and mass spectrometric quantification of the active form of a chimeric therapeutic antibody in human serum
    • PMID:18225864
    • Dubois M, Fenaille F, Clement G, Lechmann M, Tabet J-C, Ezan E, Becher F. Immunopurification and mass spectrometric quantification of the active form of a chimeric therapeutic antibody in human serum. Anal Chem 2008; 80:1737-45; PMID:18225864; http://dx. doi.org/10.1021/ac7021234
    • (2008) Anal Chem , vol.80 , pp. 1737-1745
    • Dubois, M.1    Fenaille, F.2    Clement, G.3    Lechmann, M.4    Tabet, J.-C.5    Ezan, E.6    Becher, F.7
  • 35
    • 84892754407 scopus 로고    scopus 로고
    • Emerging principles for the therapeutic exploitation of glycosylation
    • PMID:24385630
    • Dalziel M, Crispin M, Scanlan CN, Zitzmann N, Dwek RA. Emerging principles for the therapeutic exploitation of glycosylation. Science 2014; 343:1235681-1-1235681-8; PMID:24385630; http:// dx.doi.org/10.1126/science.1235681
    • (2014) Science , vol.343 , pp. 12356811-12356818
    • Dalziel, M.1    Crispin, M.2    Scanlan, C.N.3    Zitzmann, N.4    Dwek, R.A.5
  • 36
    • 0037474543 scopus 로고    scopus 로고
    • Structural analysis of human IgG-Fc glycoforms reveals a correlation between glycosylation and structural integrity
    • PMID:12527303
    • Krapp S, Mimura Y, Jefferis R, Huber R, Sondermann P. Structural analysis of human IgG-Fc glycoforms reveals a correlation between glycosylation and structural integrity. J Mol Biol 2003; 325:979-89; PMID:12527303; http://dx.doi.org/10.1016/S0022-2836(02)01250-0
    • (2003) J Mol Biol , vol.325 , pp. 979-989
    • Krapp, S.1    Mimura, Y.2    Jefferis, R.3    Huber, R.4    Sondermann, P.5
  • 37
    • 67649394336 scopus 로고    scopus 로고
    • Recombinant antibody therapeutics: The impact of glycosylation on mechanisms of action
    • PMID:19552968
    • Jefferis R. Recombinant antibody therapeutics: the impact of glycosylation on mechanisms of action. Trends Pharmacol Sci 2009; 30:356-62; PMID:19552968; http://dx.doi.org/10.1016/j.tips. 2009.04.007
    • (2009) Trends Pharmacol Sci , vol.30 , pp. 356-362
    • Jefferis, R.1
  • 38
    • 48949089988 scopus 로고    scopus 로고
    • Analysis of immunoglobulin glycosylation by LC-ESI-MS of glycopeptides and oligosaccharides
    • PMID:18655055
    • Stadlmann J, Pabst M, Kolarich D, Kunert R, Altmann F. Analysis of immunoglobulin glycosylation by LC-ESI-MS of glycopeptides and oligosaccharides. Proteomics 2008; 8:2858-71; PMID:18655055; http://dx. doi.org/10.1002/pmic.200700968
    • (2008) Proteomics , vol.8 , pp. 2858-2871
    • Stadlmann, J.1    Pabst, M.2    Kolarich, D.3    Kunert, R.4    Altmann, F.5
  • 39
    • 33947688082 scopus 로고    scopus 로고
    • Structural characterization of N-linked oligosaccharides on m onoclonal antibody cetuximab by the combination of orthogonal matrix-assisted laser desorptionionization hybrid quadrupole-quadrupole time-of-flight tandem mass spectrometry and sequential enzymatic digestion
    • PMID: 17362871
    • Qian J, Liu T, Yang L, Daus A, Crowley R, Zhou Q. Structural characterization of N-linked oligosaccharides on monoclonal antibody cetuximab by the combination of orthogonal matrix-assisted laser desorptionionization hybrid quadrupole-quadrupole time-of-flight tandem mass spectrometry and sequential enzymatic digestion. Anal Biochem 2007; 364:8-18; PMID: 17362871; http://dx.doi.org/10.1016/j.ab.2007.01.023
    • (2007) Anal Biochem , vol.364 , pp. 8-18
    • Qian, J.1    Liu, T.2    Yang, L.3    Daus, A.4    Crowley, R.5    Zhou, Q.6
  • 41
    • 50049122941 scopus 로고    scopus 로고
    • The way forward, enhanced characterization of therapeutic antibody glycosylation: Comparison of three level mass spectrometry-based strategies
    • PMID:18672411
    • Wagner-Rousset E, Bednarczyk A, Bussat M-C, Colas O, Corvaïa N, Schaeffer C, Van Dorsselaer A, Beck A. The way forward, enhanced characterization of therapeutic antibody glycosylation: comparison of three level mass spectrometry-based strategies. J Chromatogr B 2008; 872:23-37; PMID:18672411; http://dx.doi.org/ 10.1016/j.jchromb.2008.03.032
    • (2008) J Chromatogr B , vol.872 , pp. 23-37
    • Wagner-Rousset, E.1    Bednarczyk, A.2    Bussat, M.-C.3    Colas, O.4    Corvaïa, N.5    Schaeffer, C.6    Van Dorsselaer, A.7    Beck, A.8
  • 43
    • 84855860373 scopus 로고    scopus 로고
    • Simultaneous assessment of Asp isomerization and Asn deamidation in recombinant antibodies by LC-MS following incubation at elevated temperatures
    • PMID:22272329
    • Diepold K, Bomans K, Wiedmann M, Zimmermann B, Petzold A, Schlothauer T, Mueller R, Moritz B, Stracke JO, Molhoj M, et al. Simultaneous assessment of Asp isomerization and Asn deamidation in recombinant antibodies by LC-MS following incubation at elevated temperatures. Plos One 2012; 7:1-11; PMID:22272329; http://dx.doi.org/10.1371/journal. pone.0030295
    • (2012) Plos One , vol.7 , pp. 1-11
    • Diepold, K.1    Bomans, K.2    Wiedmann, M.3    Zimmermann, B.4    Petzold, A.5    Schlothauer, T.6    Mueller, R.7    Moritz, B.8    Stracke, J.O.9    Molhoj, M.10
  • 44
    • 70349769842 scopus 로고    scopus 로고
    • Human immunoglobulin allotypes: Possible implications for immunogenicity
    • PMID:20073133
    • Jefferis R, Lefranc M-P. Human immunoglobulin allotypes: Possible implications for immunogenicity. mAbs 2009; 1:332-8; PMID:20073133; http://dx.doi.org/ 10.4161/mabs.1.4.9122
    • (2009) MAbs , vol.1 , pp. 332-338
    • Jefferis, R.1    Lefranc, M.-P.2
  • 45
    • 73649091461 scopus 로고    scopus 로고
    • GlycoFi's technology to control the glycosylation of recombinant therapeutic proteins
    • PMID:22823974
    • Beck A, Cochet O, Wurch T. GlycoFi's technology to control the glycosylation of recombinant therapeutic proteins. Expert Opin Drug Disc 2010; 5:95-111; PMID:22823974; http://dx.doi.org/10.1517/ 17460440903413504
    • (2010) Expert Opin Drug Disc , vol.5 , pp. 95-111
    • Beck, A.1    Cochet, O.2    Wurch, T.3
  • 46
    • 84863470971 scopus 로고    scopus 로고
    • Marketing approval of mogamulizumab A triumph for glyco-engineering
    • PMID:22699226
    • Beck A, Reichert JM. Marketing approval of mogamulizumab A triumph for glyco-engineering. Mabs 2012; 4:419-25; PMID:22699226; http://dx.doi.org/ 10.4161/mabs.20996
    • (2012) Mabs , vol.4 , pp. 419-425
    • Beck, A.1    Reichert, J.M.2
  • 47
    • 84883860531 scopus 로고    scopus 로고
    • Correct primary structure assessment and extensive glyco-profiling of cetuximab by a combination of intact, middle-up, middle-down and bottom-up ESI and MALDI mass spectrometry techniques
    • PMID:23924801
    • Ayoub D, Jabs W, Resemann A, Evers W, Evans C, Main L, Baessmann C, Wagner-Rousset E, Suckau D, Beck A. Correct primary structure assessment and extensive glyco-profiling of cetuximab by a combination of intact, middle-up, middle-down and bottom-up ESI and MALDI mass spectrometry techniques. mAbs 2013; 5:699-710; PMID:23924801; http://dx.doi.org/ 10.4161/mabs.25423
    • (2013) MAbs , vol.5 , pp. 699-710
    • Ayoub, D.1    Jabs, W.2    Resemann, A.3    Evers, W.4    Evans, C.5    Main, L.6    Baessmann, C.7    Wagner-Rousset, E.8    Suckau, D.9    Beck, A.10


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.